It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Under normal conditions, the most significant expansion and differentiation of the adult mammary gland occurs in response to systemic reproductive hormones during pregnancy and lactation to enable milk synthesis and secretion to sustain the offspring. However, human mammary tissue remodelling that takes place during pregnancy and lactation remains poorly understood due to the challenge of acquiring samples. We report here single-cell transcriptomic analysis of 110,744 viable breast cells isolated from human milk or non-lactating breast tissue, isolated from nine and seven donors, respectively. We found that human milk largely contains epithelial cells belonging to the luminal lineage and a repertoire of immune cells. Further transcriptomic analysis of the milk cells identified two distinct secretory cell types that shared similarities with luminal progenitors, but no populations comparable to hormone-responsive cells. Taken together, our data offers a reference map and a window into the cellular dynamics that occur during human lactation and may provide further insights on the interplay between pregnancy, lactation and breast cancer.
Human mammary tissue remodelling that takes place during pregnancy and lactation remains poorly understood. Here the authors characterize cells in human milk, identifying epithelial cells resembling luminal progenitors and immune cells, contributing insights into this process.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 University of Cambridge, Department of Pharmacology, Cambridge, England (GRID:grid.5335.0) (ISNI:0000000121885934); Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, England (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791); Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
2 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
3 University of Cambridge, Department of Pharmacology, Cambridge, England (GRID:grid.5335.0) (ISNI:0000000121885934); Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, England (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791)
4 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); LMU Munich, Biomedical Center (BMC), Division of Physiological Genomics, Faculty of Medicine, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
5 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Ruhr-University Bochum, Department of Dermatology, Bochum, Germany (GRID:grid.5570.7) (ISNI:0000 0004 0490 981X)